Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer ' s Disease

Conditions: Healthy Volunteers; Down Syndrome; Alzheimer ' s Disease Interventions: Drug: Leucettinib-21 Sponsors: Perha Pharmaceuticals; France 2030 program; European Innovation Council; Fondation J érôme Lejeune Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials